Specialized stents with controlled drug delivery coatings for sustained release of active pharmaceutical ingredients. Designed to prevent restenosis and maintain vessel patency with optimized clinical performance.
Manufactured by
Freudenberg Medical Hemoteq GmbH
Würselen, Germany
Innovating together Hemoteq is a leading contract development and contract manufacturing organisation (CDMO) for device drug combination products (DDCP) and specialty coated medical devices and components. We have a proven track record backed by two decades of 360 degree expertise in advanced coating design, product and process development, regulatory strategy and volume production of DDCP and specialty coated components. Working with Hemoteq headquartered in Würselen, Germany, you get access to the global capabilities of the Freudenberg Medical group - an „innovation hub“ that enables strategic innovation at the confluence of medtech, pharma and biotech. Hemoteq operations work in accordance with applicable standards such as ISO 13485:2016.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NVENTRIC
South Korea · 1 relevant product
VascuPatent Medical (Shenzhen) Co., Ltd
China · 3 relevant products
Suzhou Silver Mars New Materials Technology Co.,Ltd.
China · 1 relevant product
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 102 closest product alternatives
NVENTRIC · South Korea
Coronary stents with pharmaceutical coating designed to prevent restenosis and promote vessel patency. These devices are used for treatment of coronary artery disease.
VascuPatent Medical (Shenzhen) Co., Ltd · China
Stent systems coated with antiproliferative medications to reduce restenosis rates. Available for coronary and peripheral vessel applications.
Suzhou Silver Mars New Materials Technology Co.,Ltd. · China
Specialized biocompatible polymer coating for drug-eluting stent platforms enabling controlled pharmaceutical release. Provides hemocompatible base layer while supporting antiproliferative drug delivery mechanisms.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products